Triangle Pharmaceuticals: Clinical Trials

7 trials sponsored by Triangle Pharmaceuticals, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 terminated, 2 unknown. 7 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 27Completed 3, Terminated 2, Unknown 2

Follow Triangle Pharmaceuticals: new trials by email

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
clevudine (drug) - Hepatitis B
Phase 2UnknownTriangle Pharmaceuticals302002-08-012005-06-24
Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults
emtricitabine, FTC (drug), didanosine, ddI (drug), efavirenz (drug) - HIV Infections, Antiretroviral Naive
Phase 2CompletedANRS, Emerging Infectious Diseases391999-02-012026-06-15
A Study of MKC-442 in HIV-Positive Patients
Emivirine - HIV Infections
Phase 2CompletedTriangle Pharmaceuticals2005-06-24
The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
Emivirine, Hydroxyurea, Delavirdine mesylate - HIV Infections
Phase 2TerminatedBristol-Myers Squibb252008-08-14
Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV
Lopinavir/Ritonavir, Emtricitabine, Stavudine - HIV Infections
Phase 2UnknownTriangle Pharmaceuticals1002005-06-24
A Study of MKC-442 in Combination With Other Anti-HIV Drugs
Emivirine, Hydroxyurea, Stavudine - HIV Infections
Phase 2CompletedTriangle Pharmaceuticals2005-06-24
The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
Emivirine, Hydroxyurea, Nevirapine - HIV Infections
Phase 2TerminatedBristol-Myers Squibb252008-08-14

Conditions studied

HIV Infections (6)  ·  Hepatitis B (1)

Interventions

Didanosine (4)  ·  Stavudine (4)  ·  emivirine (4)  ·  Hydroxyurea (3)  ·  Emtricitabine (2)  ·  Pharmaceutical Preparations (2)  ·  Delavirdine (1)  ·  Lopinavir (1)  ·  Nevirapine (1)  ·  Racivir (1)  ·  clevudine (1)  ·  efavirenz (1)

Countries

United States (5)  ·  France (2)  ·  Argentina (1)  ·  Canada (1)  ·  China (1)  ·  Mexico (1)  ·  Panama (1)  ·  Puerto Rico (1)  ·  Singapore (1)  ·  South Africa (1)

Top investigators

Genevieve Chene, MD, PhD (1)  ·  Jean-Michel Molina, MD, PhD (1)

Results publications

PMID 17591032